Our take
Edge is one of the few companies with both multi-port and single-port laparoscopic robots on the market, a pairing otherwise associated with Intuitive.1
More than half of its 100 installed or delivered systems are outside China, an unusual mix for a Chinese surgical robot maker.2
Scores by criterion
Each criterion is defined on our methodology page.
Who uses Edge and what it's for
Hospitals adding robotic urology, gynecology, general and thoracic surgery at lower system cost than da Vinci.3,2
Centers that want single-port surgery from the same vendor as multi-port.1
History
Wang Jianchen, a Tianjin University PhD, co-founded Edge Medical in Shenzhen on May 4, 2017, with Gao Yuanqian and is its chairman.4,5 The company listed on the Hong Kong Stock Exchange on January 8, 2026.4
Revenue rose 185% to RMB456 million in 2025. By December 31, 2025, Edge had installed or delivered 100 robots, 46 in China and 54 overseas.2
MP1000, SP1000 and new systems
The MP1000 multi-port and SP1000 single-port robots cover laparoscopic surgery, and Edge also sells a cloud telesurgery system and a bronchoscopic robot.1
Global clinical procedures on Edge robots passed 20,000, including more than 3,000 single-port cases, and Edge has added NMPA-approved instruments and a robotic ultrasonic scalpel.2
Pricing
In 2025 Chinese public hospital tenders, Edge's multi-port robots averaged about RMB14.53 million (about $2 million) per system, and Edge won 16 systems.3
Instruments and consumables are sold per procedure.2
Competitive landscape
| Company | Product | Pricing model | Deployment footprint | Where Edge wins or loses |
|---|---|---|---|---|
| Edge Medical | MP1000 multi-port and SP1000 single-port robots1 | About RMB14.53M average tender price in China3 | 100 robots installed or delivered, 54 overseas2 | Multi-port and single-port robots with overseas installs |
| Intuitive (da Vinci) | da Vinci multi-port and single-port surgical systems6 | Sales plus leases, many with usage-based payments6 | About 12,094 systems installed at September 30, 20266 | Intuitive wins on installed base and instruments. Edge wins on price. |
| CMR Surgical (Versius) | Versius Plus modular surgical robot7 | Not published7 | 45,000 cases worldwide; FDA 510(k) for gallbladder removal7 | CMR wins on modular carts in Europe. Edge wins on single-port. |
| SS Innovations | SSi Mantra modular surgical robot8 | Less than a third of a da Vinci's price in a 2022 report9 | 224 systems in twelve countries by June 30, 2026; not yet FDA cleared10,11 | SS Innovations wins on lowest system cost. Edge wins on single-port and scale. |
| Distalmotion (DEXTER) | DEXTER soft-tissue surgical robot with a small, mobile footprint12 | Not published12 | Almost 3,000 patients treated; three US clearances12 | Distalmotion wins on open-console design. Edge wins on product breadth. |
Limits
Utilization of Chinese surgical robots still trails da Vinci, which averages more than 400 procedures per system a year in China.2
Price competition in Chinese hospital tenders is intense.3
Edge's instrument catalog is still catching up with da Vinci staplers and vessel sealers.2
What customers say
Where it helps
Hospitals that want both multi-port and single-port robots from one supplier get the most from Edge.1
Buyers in markets where Edge already has overseas installs can check local references.2
Where it falls short
Hospitals wanting the deepest instrument catalog should look at Intuitive; buyers wanting the lowest system cost should look at SS Innovations.
Leadership

Wang Jianchen
Founder and chairmanWang, a Tianjin University PhD, founded Edge Medical and led it to a Hong Kong listing in January 2026.4
Sources
- Edge Medical, Homepage, accessed November 9, 2026
- VCBeat, Utilization of China-made endoscopic surgical robots, May 27, 2026, accessed November 9, 2026
- MedChina, 2025 China laparoscopic surgical robot tender report, accessed November 9, 2026
- National Business Daily, Edge Medical chairman Wang Jianchen at Hong Kong listing, January 8, 2026, accessed November 9, 2026
- Chief Group, Edge Medical (2675) IPO details, accessed November 9, 2026
- Intuitive Surgical, Form 10-Q for the quarter ended September 30, 2026, accessed November 1, 2026
- CMR Surgical, Home page, accessed November 1, 2026
- SS Innovations, Investor overview, accessed November 1, 2026
- Business Standard, SSI Mantra costs one-third of global price, September 15, 2022, accessed November 1, 2026
- SS Innovations, Second quarter 2026 financial results, August 13, 2026, accessed October 31, 2026
- SS Innovations, Response to FDA request for additional information on the SSi Mantra 510(k), October 13, 2026, accessed October 31, 2026
- Distalmotion, Distalmotion raises $150 million, November 18, 2025, accessed November 1, 2026


